Oral Session 1-5D MM and myeloma related diseases

[OS1-5D-6] Analysis of 230 cases of thalidomide monotherapy for symptomatic myeloma registered in KMF

Hitomi Kaneko^1,20, Hirohiko Shibayama^2,20, Hideo Yagi^3,20, Junya Kanda^4,20, Aya Nakaya^5,20, Satoru Kosugi^6,20, Toru Kida^6,20, Hirokazu Tanaka^7,20, Yuji Shimura^8,20, Shin-Ichi Fuchida^9,20, Yoko Adachi^10,20, Katsuya Wada^11,20, Miki Kiyota^11,20, Nobuhiko Uoshima^12,20, Kensuke Ohta^13,20, Takae Kohara^14,20, Tsuneyoshi Hamada^15,20, Masayuki Kobayashi^15,20, Hitoji Uchiyama^16,20, Takahiro Karasuno^17,20, Junya Kuroda^8,20, Kazunori Imada^1,20, Akifumi Takaori-Kondo^4,20, Chihiro Shimazaki^9,20, Yuzuru Kanakura^2,20, Masayuki Hino^18,20, Shosaku Nomura^19,20, Itaru Matsumura^7,20 (1.Department of Hematology, Osaka Red Cross Hospital, Osaka, Japan, 2.Department of Hematology and Oncology, Osaka Univ., Osaka, Japan, 3.Department of Hematology and Oncology, Nara Prefecture General Medical Center, 4.Department of Hematology and Oncology, Kyoto Univ., Kyoto, Japan, 5.Division of hematology, Kansai Medical University Medical Center, Osaka, Japan, 6.Department of Internal Medicine (Hematology), Toyonaka Municipal Hospital, Osaka, Japan, 7.Department of Hematology and Rheumatology, Kindai Univ., Osaka, Japan, 8.Division. of Hematology and Oncology, Kyoto Prefectural Univ., Kyoto, Japan, 9.Department of Hematology, JCHO Kyoto Kuramaguchi Medical Center, Kyoto, Japan, 10.JCHO Kobe Central Hospital, Department of Internal Medicine, Kobe, Japan, 11.Department of Hematology, Matsushita Memorial Hospital, Osaka, Japan, 12.Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Japan, 13.Department of Hematology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan, 14.Department of Hematology, Sakai City Medical Center, Osaka, Japan, 15.Hematology Div. Int. Med., Kyoto-Katsura Hospital, Kyoto, Japan, 16.Japanese Red Cross Kyoto Daiichi Hospital, Department of Hematology, Japan, 17.Department of Hematology, Rinku General Medical Center, Osaka, Japan, 18.Hematology, Osaka City University Graduate School of Medicine, Osaka, Japan, 19.First Department of Internal Medicine, Kansai Medical University, Osaka, Japan, 20.Kansai Myeloma Forum)